| 标题 |
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction |
| 网址 | |
| DOI |
10.1001/jamacardio.2025.4491
doi
|
| 其它 |
Randomized Controlled Trial JAMA Cardiol . 2026 Jan 1;11(1):89-97. doi: 10.1001/jamacardio.2025.4491. Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction Paul M Ridker 1 2, Florian M M Baeres 3, Anders Hveplund 3, Mads M D Engelmann 3, G Kees Hovingh 3, A Michael Lincoff 4, Nikolaus Marx 5, Ann Marie Navar 6 7, Naveed Sattar 8, Katherine Tuttle 9, Vlado Perkovic 10 Affiliations expand PMID: 41369941 DOI: 10.1001/jamacardio.2025.4491 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)